Targeting SIRTI By Isoflavone for the Treatment of Type 2 Diabetes and its Complications

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkki:	Oza Manisha
Materiálatiipa:	Oahppočájánas Girji
Giella:	eaŋgalasgiella
Almmustuhtton:	Mumbai NMIMS-SPPSPTM 2019
Fáttát:	SIRTI > Isoflavone > Diabetes > Complications
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

MARC


LEADER	00000nam a22000007a 4500
008	211007b xxu\|\|\|\|\| \|\|\|\| 00\| 0 eng d
999		\|c 406412 \|d 406412
100		\|a Oza Manisha \|9 43616
245		\|a Targeting SIRTI By Isoflavone for the Treatment of Type 2 Diabetes and its Complications
260		\|a Mumbai \|b NMIMS-SPPSPTM \|c 2019
300		\|a i,xix, 1-363
502		\|a CD not Received \|b Ph.D \|c NMIMS-SPPSPTM \|d 2019
504		\|a Kulkarni A Yogesh
650		\|a SIRTI \|a Isoflavone \|a Diabetes \|a Complications \|9 44355
952		\|0 0 \|1 0 \|2 ddc \|4 0 \|7 0 \|9 469547 \|a 00004532 \|b 00004532 \|d 2021-10-07 \|l 0 \|p SBMPH248 \|r 2021-10-07 \|w 2021-10-07 \|y PH